Isoquinolinone potassium channel inhibitors

Details for Australian Patent Application No. 2004276238 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Dinsmore, Christopher J.; Claremon, David A.; Mcintyre, Charles J.; Bergman, Jeffrey M.; Isaacs, Richard

Agent Spruson & Ferguson

Pub. Number AU-B-2004276238

PCT Pub. Number WO2005/030726

Priority 60/505,215 23.09.03 US

Filing date 17 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 28 October 2010

International Classifications

C07D 217/24 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030726 Priority application(s): WO2005/030726

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

28 October 2010 Application Accepted

  Published as AU-B-2004276238

24 February 2011 Standard Patent Sealed

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004276240-6-[(substituted)phenyl]triazolopyrimidine s as anticancer agents

2004276237-Quinoline potassium channel inhibitors